Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|May 10, 2012
Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I studyD Strumberg, M E Scheulen, B Schultheis, et al.
Transplantation|September 1, 1990
Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantationD W Beelen, K Quabeck, B Kaiser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancerM Schmidt, M E Scheulen, C Dittrich, et al.
Investigational New Drugs|December 21, 2010
Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancerDirk Strumberg, Beate Schultheis, M E Scheulen, et al.
Annals of Hematology|December 2, 2000
Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemiaM Flasshove, P Meusers, J Schütte, et al.
British Journal of Cancer|June 16, 2012
A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative networkK Mross, C Dittrich, W E Aulitzky, et al.
British Journal of Cancer|November 13, 2008
Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumoursD Strumberg, B Schultheis, I A Adamietz, et al.
Breast Cancer Research and Treatment|July 23, 2013
A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancerErica L Mayer, M E Scheulen, J Beckman, et al.
Bone Marrow Transplantation|August 10, 2004
High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancerP Bojko, A Welt, R Schleucher, et al.
Journal of Cancer Research and Clinical Oncology|January 17, 2004
Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphomaS Koeppen, C C P Verstappen, R Körte, et al.
Pageof 7